- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Anti-PD1 antibody, nimotuzumab and capecitabine
Total 3242 results
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingColorectal Cancer | Multiple CancerChina
-
Ruijin HospitalRecruiting
-
Guangzhou FineImmune Biotechnology Co., LTD.RecruitingAdvanced Solid Tumor | Immunotherapy | Tumor Associated Lymph Node T CellChina
-
Shanghai Zhongshan HospitalRecruiting
-
Bio-Thera SolutionsNot yet recruiting
-
University of Colorado, DenverNational Cancer Institute (NCI); Cancer League of ColoradoWithdrawnColorectal Cancer | Microsatellite Instability High | Mismatch Repair DeficiencyUnited States
-
University Hospital, MontpellierCompletedPatients Recieving Anti-PD-1 or Anti-PD-L1 ImmunotherapiesFrance
-
Tianjin Medical University Cancer Institute and...Completed
-
H. Lee Moffitt Cancer Center and Research InstituteSanofiTerminatedPancreatic NeoplasmsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMalignant Mesothelioma | CD30-Positive Neoplastic Cells PresentUnited States
-
Gilead SciencesCompletedPancreatic CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Invasive Breast Carcinoma | HER2/Neu Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
Shanghai Henlius BiotechWithdrawn
-
PfizerCompletedAdult Relapsed/Refractory B Cell Acute Lymphoblastic LeukemiaIndia
-
Changhai HospitalRecruitingPancreatic Neoplasms | Pancreatic Cancer | Advanced Cancer | Pancreatic Ductal AdenocarcinomaChina
-
University Hospital, Basel, SwitzerlandSanofi; Roche Pharma AG; Swiss National Science Foundation; Swiss Cancer LeagueCompletedMetastatic Pancreatic Cancer | Locally Advanced Pancreatic CancerSwitzerland
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer
-
Ruijin HospitalNot yet recruitingMuscle-Invasive Bladder CarcinomaChina
-
Mayo ClinicCompletedLymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | High Risk Myelodysplastic SyndromeUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedEosinophilic AsthmaUnited States, Australia, Belgium, Chile, Colombia, Denmark, Hungary, Israel, Malaysia, New Zealand, Philippines, Poland, Russian Federation, South Africa, Sweden, Thailand, Argentina, Brazil, Canada, France, Mexico, Netherlands, Ge... and more
-
ITabMed Co., Ltd.Not yet recruitingRecurrent or Metastatic Solid Tumors
-
Luye Pharma Group Ltd.Shang Dong Boan Biotechnology Co., Ltd (Co-sponsor)RecruitingPostmenopausal OsteoporosisChina
-
National Institute of Allergy and Infectious Diseases...GlaxoSmithKline; Rho Federal Systems Division, Inc.; Inner-City Asthma ConsortiumCompleted
-
Ohio State University Comprehensive Cancer CenterCompleted
-
EVIVE BiotechnologyPeking University Cancer Hospital & InstituteUnknownRelapsed or Refractory B-cell Lymphoma
-
Sherief Abd-ElsalamUnknownHepatitis B VaccinesEgypt
-
Hopital FochCompleted
-
Sichuan Kelun Pharmaceutical Research Institute...307 Hospital of PLAUnknownMetastatic Colorectal CancerChina
-
Peking Union Medical College HospitalNot yet recruitingLocally Advanced Rectal Cancer
-
Baxalta now part of ShireCompletedMalignant Solid Tumors | Metastatic Adenocarcinoma of the Colon or RectumGermany, United States
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityRecruitingNasopharyngeal Carcinoma | Capecitabine | Radiotherapy | PD-1 InhibitorChina
-
Klinikum der Universitaet Muenchen, GrosshadernLudwig-Maximilians - University of Munich; The European Society for Hyperthermic...Unknown
-
Tianjin Medical University Cancer Institute and...UnknownMetastatic Breast CancerChina
-
SYZ Cell Therapy Co..Recruiting
-
Rockefeller UniversityNational Institute of Allergy and Infectious Diseases (NIAID); Montefiore Medical... and other collaboratorsCompleted
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedLung CancerUnited States, Canada
-
Ruijin HospitalRecruitingEsophageal Squamous Cell CarcinomaChina
-
Hoffmann-La RocheCompletedBladder CancerUnited States, France, Belgium, Korea, Republic of, United Kingdom, Czechia, Austria, Canada, Denmark, Greece, Italy, Netherlands, Portugal, Slovenia, Spain, Sweden, Turkey, Poland, Hungary, Switzerland, Japan, Taiwan, Australia, Norway, Germa... and more
-
Swiss Group for Clinical Cancer ResearchCentral European Cooperative Oncology GroupCompletedPancreatic CancerSwitzerland, Italy, Israel, Austria
-
Cambridge University Hospitals NHS Foundation TrustCompletedIslet Cell Tumor | Gastrointestinal Carcinoid TumorUnited Kingdom
-
Cancer Research UKCompletedPancreatic CancerUnited Kingdom
-
Asan Medical CenterCompleted
-
Stanford UniversityMerck Sharp & Dohme LLCActive, not recruitingHodgkin Lymphoma | Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Relapsed Classical Hodgkin LymphomaUnited States
-
Celldex TherapeuticsCompletedMetastatic gpNMB Over-expressing Triple Negative Breast CancerUnited States, France, Spain, Italy, Canada, Germany, Australia, Belgium, United Kingdom
-
GlaxoSmithKlineCompleted
-
Assistance Publique - Hôpitaux de ParisEtablissement Français du Sang (Nouvelle Aquitaine)Recruiting
-
Memorial Sloan Kettering Cancer CenterRockefeller University; Pin Down Bladder Cancer Research FoundationRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Xiujuan ZhaoUnknown